Development and Characterization of Niosomal Drug Delivery of Gliclazide

被引:37
|
作者
Tamizharasi, S. [1 ]
Dubey, A. [1 ]
Rathi, V [2 ]
Rathi, J. C. [2 ]
机构
[1] Nandha Coll Pharm, Dept Pharmaceut, Erode 638052, Tamil Nadu, India
[2] NRI Inst Pharmaceut Sci, Dept Pharmaceut, 3 Sajjan Singh Nagar,Opp Patel Nagar, Bhopal 462026, Madhya Pradesh, India
关键词
Niosomes; gliclazide; cholesterol;
D O I
10.4103/0975-1483.57065
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, gliclazide-loaded niosomes are formulated and evaluated for their in vitro as well as in vivo characteristic in an attempt to improve the oral bioavailability of the drug. Formulation of niosomes was optimized for highest percentage of drug entrapment. Microscopic observation confirmed that all particles were uniform in size and shape. The entrapment efficiency was determined by separating the unentrapped drug using dialysis. The in vitro release studies of drug from niosomes exhibited a prolonged drug release as observed over a period of 24 h. The positive values of zeta potential indicated that the gliclazide niosomes were stabilized by electrostatic repulsive forces. Results from stability study have shown that the drug leakage from the vesicles was least at 4 degrees C followed by 25 and 37 degrees C. The niosomes showing maximum entrapment and suitable release rate were selected for in vivo evaluation. In conclusion, the niosomal formulation could be a promising delivery system for gliclazide with improved bioavailability and prolonged drug release profile.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 50 条
  • [41] Brij Niosomes as Carriers for Sustained Drug Delivery _ A Fluorescence-Based Approach to Probe the Niosomal Microenvironment
    Sarkar, Sudeshna
    De, Swati
    LANGMUIR, 2022, 38 (16) : 4521 - 4537
  • [42] Preparation and Characterization of Chitosan Microparticles for Oral Sustained Delivery of Gliclazide: In Vitro/In Vivo Evaluation
    Barakat, Nahla S.
    Almurshedi, Alanood S.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (03) : 235 - 246
  • [43] Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery
    Teaima, Mahmoud H.
    El Mohamady, Ahmed M.
    El-Nabarawi, Mohamed A.
    Mohamed, Amir I.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (05) : 751 - 761
  • [44] Preparation and Characterization of Topical Niosomal Formulation Containing Retinyl Palmitate and Squalane for Enhanced Skin Delivery
    Sagiroglu, Ali Asram
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 (05): : 1821 - 1830
  • [45] Formulation and characterisation of lacidipine niosomal gel for transdermal delivery
    Mapari, Salika Santosh
    DCruz, Cleona Elizabeth Mary
    Kumar, Lalit
    Bhide, Prashant Jivaji
    Shirodkar, Rupesh Kalidas
    TENSIDE SURFACTANTS DETERGENTS, 2023, 60 (02) : 124 - 139
  • [46] Electrochemical oxidation of the hypoglycaemic drug gliclazide
    Radi, A
    El Ries, MA
    Bekhiet, GE
    ANALYTICAL LETTERS, 1999, 32 (08) : 1603 - 1612
  • [47] Fabrication and Characterization of Gliclazide Nanocrystals
    Ravouru, Nagaraju
    Venna, Rajeswari Surya Anusha
    Penjuri, Subhash Chandra Bose
    Damineni, Saritha
    Kotakadi, Venkata Subbaiah
    Poreddy, Srikanth Reddy
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (03) : 419 - 427
  • [48] Optimization of propofol loaded niosomal gel for transdermal delivery
    Zhang, Wenjia
    Zhao, Xu
    Yu, Guanling
    Suo, Meng
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2021, 32 (07) : 858 - 873
  • [49] Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine
    Aldawsari, Mohammed F.
    Khafagy, El-Sayed
    Moglad, Ehssan H.
    Lila, Amr Selim Abu
    SAUDI PHARMACEUTICAL JOURNAL, 2023, 31 (09)
  • [50] Development and Characterization of Salmeterol Xinafoate Niosomes for Nasal Delivery
    Mouzam, Md. Ismail
    Dehghan, M. H. G.
    Shaikh, Samina M.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2011, 45 (02) : 121 - 127